We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMH icon
876
VanEck Semiconductor ETF
SMH
$70.6B
$7.66M 0.01%
175,626
-85,094
-33% -$3.99M
VALE icon
877
Vale
VALE
$63B
$7.66M 0.01%
580,729
+79,674
+16% +$1.14M
PB icon
878
Prosperity Bancshares
PB
$8.84B
$7.66M 0.01%
122,924
+7,302
+6% +$482K
RGT
879
Royce Global Value Trust
RGT
$102M
$7.66M 0.01%
862,220
-427
-0% -$4.01K
BWA icon
880
BorgWarner
BWA
$14.2B
$7.64M 0.01%
249,919
+70,127
+39% +$2.35M
JRVR icon
881
James River Group Holdings
JRVR
$210M
$7.63M 0.01%
208,785
-11,110
-5% -$423K
IDXX icon
882
Idexx Laboratories
IDXX
$47.3B
$7.63M 0.01%
40,989
+8,911
+28% +$1.83M
DES icon
883
WisdomTree US SmallCap Dividend Fund
DES
$2.2B
$7.61M 0.01%
310,011
-13,594
-4% -$370K
UHS icon
884
Universal Health Services
UHS
$10.5B
$7.58M 0.01%
65,006
+7,676
+13% +$965K
FLO icon
885
Flowers Foods
FLO
$1.51B
$7.58M 0.01%
410,116
-91,024
-18% -$1.74M
KDP icon
886
Keurig Dr Pepper
KDP
$40B
$7.57M 0.01%
295,042
+185,707
+170% +$4.72M
CSQ icon
887
Calamos Strategic Total Return Fund
CSQ
$3.37B
$7.56M 0.01%
713,524
+32,558
+5% +$382K
CHTR icon
888
Charter Communications
CHTR
$18.1B
$7.55M 0.01%
26,495
+2,735
+12% +$858K
WFC.PRL icon
889
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$7.51M 0.01%
5,954
-462
-7% -$585K
PVH icon
890
PVH
PVH
$4B
$7.5M 0.01%
80,692
-29,144
-27% -$3.34M
QEMM icon
891
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$60.1M
$7.49M 0.01%
137,715
-6,175
-4% -$345K
HCA icon
892
HCA Healthcare
HCA
$89.3B
$7.43M 0.01%
59,743
+1,371
+2% +$184K
VIS icon
893
Vanguard Industrials ETF
VIS
$8.46B
$7.43M 0.01%
61,677
-8,822
-13% -$1.17M
BKLN icon
894
Invesco Senior Loan ETF
BKLN
$6.74B
$7.4M 0.01%
339,690
-24,792
-7% -$564K
GHY
895
PGIM Global High Yield Fund
GHY
$481M
$7.39M 0.01%
571,965
+22,675
+4% +$302K
MGC icon
896
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$7.39M 0.01%
85,056
+21,896
+35% +$2.05M
RCL icon
897
Royal Caribbean
RCL
$82.5B
$7.39M 0.01%
75,524
-61,211
-45% -$6.71M
L icon
898
Loews
L
$23.3B
$7.37M 0.01%
161,922
+8,846
+6% +$417K
PXH icon
899
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
$7.36M 0.01%
372,489
-40,396
-10% -$817K
AMH icon
900
American Homes 4 Rent
AMH
$12.3B
$7.36M 0.01%
370,568
-149,504
-29% -$3.06M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.